BRIEF—Hikma appoints new CEO

Hikma Pharmaceuticals has appointed Sigurdur Olafsson as chief executive, with immediate effect. Current CEO and chairman Said Darwazah will become executive chairman.

Mr Olafsson was most recently president and CEO of the global generics group of Teva Pharmaceuticals, and was previously president of Actavis.

The firm said Mr Olafsson, who will report to Mr Darwazah, would “focus on opportunities to accelerate growth of the global business.”

As executive chairman Mr Said will “guide, oversee, and engage with the chief executive in setting and delivering the strategic vision for the company,” the firm said.